RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
-5.97%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$522M
AUM Growth
+$522M
(-17%)
Cap. Flow
-$70.4M
Cap. Flow
% of AUM
-13.5%
Top 10 Holdings %
Top 10 Hldgs %
27.83%
Holding
119
New
12
Increased
37
Reduced
37
Closed
11
Top Buys
| 1 |
Gilead Sciences
GILD
|
$18.6M |
| 2 |
Medtronic
MDT
|
$15.3M |
| 3 |
Pfizer
PFE
|
$10.8M |
| 4 |
Elevance Health
ELV
|
$8.38M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$5.42M |
Top Sells
| 1 |
SHPG
Shire pic
SHPG
|
$26.6M |
| 2 |
CELG
Celgene Corp
CELG
|
$10.8M |
| 3 |
UnitedHealth
UNH
|
$8.8M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$8.56M |
| 5 |
Merck
MRK
|
$7.65M |
Sector Composition
| 1 | Healthcare | 94.79% |
| 2 | Financials | 1.61% |
| 3 | Technology | 0.16% |
| 4 | Energy | 0.11% |
| 5 | Consumer Discretionary | 0.05% |
